St. Vincent's Medical Center is a 473-bed tertiary care Catholic hospital in Bridgeport, Connecticut, United States. It caters to a large population in Southern Connecticut and provides comprehensive and advanced medical services.

There are 473 beds in Hartford HealthCare - Saint Vincent's Medical Center.

During the past decade, Hartford HealthCare - Saint Vincent's Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hartford HealthCare - Saint Vincent's Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "NRG Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hartford HealthCare - Saint Vincent's Medical Center" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hartford HealthCare - Saint Vincent's Medical Center" are "Fallopian Tube Endometrioid Adenocarcinoma" (2 trials), "Fallopian Tube Mucinous Adenocarcinoma" (2 trials), "Fallopian Tube Transitional Cell Carcinoma" (2 trials), "Ovarian Brenner Tumor" (2 trials) and "Ovarian Clear Cell Adenocarcinofibroma" (2 trials). Many other conditions were trialed in "Hartford HealthCare - Saint Vincent's Medical Center" in a lesser frequency.

Most popular intervention types in "Hartford HealthCare - Saint Vincent's Medical Center" are "Drug" (9 trials), "Other" (9 trials), "Radiation" (8 trials), "Biological" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Quality-of-Life Assessment" (6 trials), "Paclitaxel" (5 trials), "Bevacizumab" (4 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hartford HealthCare - Saint Vincent's Medical Center" are 5 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hartford HealthCare - Saint Vincent's Medical Center". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hartford HealthCare - Saint Vincent's Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hartford HealthCare - Saint Vincent's Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".